Influx Healthtech Ltd (INFLUX) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Influx Healthtech Ltd on NSE and BSE, with an AI summary of each filing.
Influx Healthtech Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
Outcome · 04 Nov 2026, 9:13 pm
Influx Healthtech Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
Outcome · 04 Nov 2026, 8:58 pm
Influx Healthtech Limited has informed the Exchange about Schedule of Investor Conference Call
Intimation · 05 Nov 2026, 1:30 pm
Influx Healthtech Schedules H1FY27 Earnings Conference Call for 5th Nov'26 Influx Healthtech Limited will host an investor conference call on 5th Nov'26 at 13:30 Hrs IST to discuss its unaudited financial results for the quarter and half-year ended 30th Sep'26 (H1FY27). The call follows the company's Board of Directors meeting scheduled for 4th Nov'26. Management will be represented by Dr. Munir Chandniwala (Managing Director & Chairman) and Mr. Ashish Shah (Chief Financial Officer).
INFLUX HEALTHTECH LIMITED has informed the Exchange about Board Meeting to be held on 04-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 .
Intimation · 04 Nov 2026, 5:30 am
Influx Healthtech Schedules Board Meeting to Approve Half-Yearly Results Influx Healthtech Limited has notified the Exchange that its Board of Directors will meet on 4th Nov'26. The primary agenda is to consider and approve the company's unaudited financial results for the half-year ended Sep'26.
To consider and approve the financial results for the period ended September 30, 2026
Intimation · 04 Nov 2026, 5:30 am
Influx Healthtech Schedules Board Meeting to Approve H1 FY27 Results Influx Healthtech Limited has scheduled its Board of Directors meeting for 4th Nov'26 to consider and approve the unaudited standalone and consolidated financial results, along with the Limited Review Report, for the half-year ended 30th Sep'26. Additionally, the trading window for dealing in company securities remains closed for directors, promoters, designated persons, and their immediate relatives until 48 hours after the dissemination of the results.
Influx Healthtech Limited has informed the Exchange about Imposition of Fine by NSE Ltd.
Others (Uncategorized) · 24 Sept 2026, 11:50 pm
NSE Rejects Influx Healthtech's Waiver Application and Levies Fine NSE's Committee for Review of Penalties rejected Influx Healthtech Limited's waiver application on 23rd Sep'26, imposing a fine of Rs. 1,55,000 plus GST (aggregating Rs. 1,82,900) for 31 days of non-compliance under Regulation 33 of SEBI LODR Regulations. The penalty pertains to delayed submission of consolidated half-yearly financial results for the period ended 31st Mar'26. The company stated the filing delay arose from submitting revised consolidated half-yearly figures following subsidiary incorporation, with financial impact strictly limited to the fine amount.
Influx Healthtech Limited has informed the Exchange about Schedule of Analyst / Institutional Investor meetings
Intimation · 23 Sept 2026, 7:06 pm
Influx Healthtech Schedules Virtual Institutional Investor Interaction Influx Healthtech Ltd. announced that company officials will participate in a virtual group investor meeting at the "Rising Stars by Arihant Capital - Bharat Connect Conference" on 25th Sep'26, from 11:00 AM to 12:00 PM. Discussions will rely solely on publicly available information, with no unpublished price-sensitive information (UPSI) to be shared.
Influx Healthtech Limited has submitted the Exchange a copy of the Scrutiniser s Report and Voting Results of its 6th Annual General Meeting held on September 18, 2026.
Annual General Meeting · 19 Sept 2026, 6:44 pm
Influx Healthtech Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 18, 2026
Annual General Meeting · 18 Sept 2026, 11:18 pm
Influx Healthtech Limited has informed the Exchange regarding 'Dispatch of Letters to Shareholders under Regulation 36(1)(b) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015'.
Others (Uncategorized) · 10 Sept 2026, 7:21 pm
Influx Healthtech Dispatches FY26 Annual Report Weblinks and Schedules 6th AGM Influx Healthtech Limited has dispatched communications to shareholders with unregistered email addresses as of the 21st Aug'26 cut-off date, providing access links to its FY25-26 Annual Report pursuant to SEBI Listing Regulations. Additionally, the company announced that its 6th Annual General Meeting is scheduled for 18th Sep'26 at 12:00 PM IST via Video Conferencing/OAVM. Shareholders holding physical securities were also reminded to complete mandatory KYC updates, register nominations, and dematerialize shares in compliance with SEBI circulars.
Influx Healthtech Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 18, 2026
Annual General Meeting · 26 Aug 2026, 9:17 pm
Influx Healthtech Limited has informed the Exchange regarding Outcome of Board Meeting held on August 26, 2026.
Outcome · 26 Aug 2026, 9:08 pm
Influx Healthtech Sets 6th Annual General Meeting for Sep'26 The Board of Directors, in its meeting on 26 Aug'26, approved the Directors' Report for the financial year ended 31 Mar'26. The 6th Annual General Meeting (AGM) has been scheduled for 18 Sep'26. Additionally, M/s. PNK & Co., Practicing Company Secretaries, were appointed as the Scrutinizer for the upcoming AGM.
Influx Healthtech Limited has informed the Exchange regarding 'Business Update for the Quarter Ended June 30, 2026 (Q1FY27)'.
Others (Uncategorized) · 10 Jul 2026, 9:46 pm
Influx Healthtech Guides for Strong FY27 Growth Driven by Major Capacity Expansion Influx Healthtech reported a strong Q1FY27, driven by its nutraceutical segment, improved operating efficiencies, and margin expansion. The company has reallocated ₹10 Crs to more than double its nutraceutical CDMO facility to 75,000 sq. ft., which is expected to be operational by Aug'26 and increase total manufacturing capacity by 2.5x. Management guided for FY27 topline growth of 25-30% with EBITDA margins of 20-22%, supported by this expansion and strong demand across its product verticals, including pet nutrition and beverages.
The Exchange had sought clarification from Influx Healthtech Limited for the quarter ended 31-Mar-2026 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Half Yearly figures not submitted by the Company The response of the Company is enclosed.
Others (Uncategorized) · 03 Jul 2026, 4:33 pm
Influx Healthtech Clarifies FY26 Consolidated Financials Post-Exchange Query Influx Healthtech submitted a clarification to the exchange regarding its consolidated financials for the half-year and year ended 31 Mar'26. The company modified its Consolidated Profit & Loss statement format following an exchange query. The change addresses the incorporation of its subsidiary, Olahey Wellness Private Limited, on 03 Feb'26, ensuring only relevant half-year figures are presented. For FY26, the company reported consolidated revenue of Rs. 14,816.85 lakhs and a Net Profit of Rs. 2,053.87 lakhs.